• Platform

  • Aktiesparekonto

  • Priser

  • Blog

  • MCP

  • Support

  • Populære aktier

InstagramLinkedInTikTokFacebook
Opret konto
Få appenScan koden
QR-kode til download af Endavu-appen
Log ind
Biotechnology Assets
Biotechnology Assets
Bolsa de Madrid

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I BIOTECHNOLOGY ASSETS MED ENDAVU: Køb Biotechnology Assets ($BST2) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Biotechnology Assets, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Om

Biotechnology Assets, S.A. is a biotechnology company focused on developing, producing, and commercializing biological solutions for pharmaceutical, healthcare, animal health, agricultural, cosmetic, and chemical applications. Its portfolio includes SPLITTERA, a platform designed for site-specific protein conjugation; Click Car, which provides universal connectors for Split-CAR applications; VACC-ZERA, a tool for producing recombinant proteins in microparticles; and CLICK’N CUT, a technology for tag-free protein purification. The company also works with active therapeutic substances, recombinant proteins, vaccines, probiotics, feed additives, and other specialized biotechnological products. Biotechnology Assets, S.A. serves organizations involved in biopharmaceutical research, drug development, veterinary care, agriculture, and industrial biotechnology, while supporting the development, transfer, licensing, and commercialization of intellectual property. Headquartered in Jerez de la Frontera, Spain, the company occupies a specialized position in the biotechnology market by connecting research capabilities with practical platforms for protein engineering, biomanufacturing, and health-related applications.

Information

TickerBST2
Land
Spanien
Antal medarbejdere26
Hjemmesidebiatgroup.com
SektorSundhed
IndustriBioteknologi

Udbytter

0,13EUR
'22
Ex-udbytte-dato6. jun. 2022
Udbytteafkast0%